5-Fluoro-2-Oxindole CAS 56341-41-4 Tsarkake>99.0% (LCMS) Sunitinib Malate Matsakaici Factory

Takaitaccen Bayani:

Sunan Sinadari: 5-Fluoro-2-Oxindole

Saukewa: 56341-41

Tsafta:> 99.0% (LCMS)

Bayyanar: Hasken Yellow Crystalline Foda

Matsakaicin Sunitinib Malate (CAS: 341031-54-7)

Kyakkyawan inganci, Samar da Kasuwanci

E-Mail: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Shanghai Ruifu Chemical Co., Ltd. shine babban masana'anta da mai ba da kayayyaki na 5-Fluoro-2-Oxindole (CAS: 56341-41-4) tare da inganci mai inganci, samar da kasuwanci.Maraba don yin oda.

Abubuwan Sinadarai:

Sunan Sinadari 5-Fluoro-2-Oxindole
Makamantu 5-Fluorooxindole;5-Fluoro-2-indolinone;5-Fluoroindolin-2-daya;5-Fluoro-1,3-Dihydro-indol-2-daya
Lambar CAS 56341-41-4
Lambar CAT Saukewa: RF-PI1543
Matsayin Hannun jari A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton
Tsarin kwayoyin halitta C8H6FNO
Nauyin Kwayoyin Halitta 151.14
Yawan yawa 1.311± 0.06 g/cm3
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Hasken Rawaya Crystalline Foda
1 H NMR Spectrum Daidaita Da Tsarin
LCMS Daidaita Da Tsarin
Tsarkake / Hanyar Bincike > 99.0% (LCMS)
Matsayin narkewa 143.0 ~ 147.0 ℃
Asara akan bushewa <0.50%
Jimlar ƙazanta <1.00%
Matsayin Gwaji Matsayin Kasuwanci
Amfani Matsakaicin Magunguna;Sunitinib Malate Intermediate

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / Kwali Drum, ko bisa ga abokin ciniki ta bukata.

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi.

Amfani:

1

FAQ:

Aikace-aikace:

5-Fluoro-2-Oxindole (CAS: 56341-41-4) galibi ana amfani dashi a cikin masana'antar harhada magunguna azaman matsakaicin magunguna.5-Fluoro-2-Oxindole matsakaici ne a cikin haɗin Sunitinib Malate (CAS: 341031-54-7).Sunitinib Malate wani nau'in novel ne na maganin ciwon daji da aka yi niyya na baka da yawa kuma yana cikin mai hana tyrosine kinase mai yawan niyya tare da sunan kasuwancinsa shine "Suntent".Kamfanin Pfizer ne ya haɓaka shi cikin nasara kuma yana da tasirin anti-tumor biyu.Bugu da ƙari, ita ce kawai maganin warkewa wanda zai iya wuce tsawon shekaru 2 na rayuwa na ciwon daji na koda na ci gaba kuma yana taka muhimmiyar rawa a fagen ciwon daji da gastrointestinal stromal tumor therapeutic area.Ya shiga kasuwa a watan Fabrairun 2006 a Amurka.Wannan maganin shine maganin cutar kansa na farko wanda FDA ta Amurka ta amince kuma yana iya magance cututtuka guda biyu lokaci guda.

Ku rubuta sakonku anan ku aiko mana